FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients. However, the FDA pointed to the drug’s benefits, as well. “Alzheimer’s disease immeasurably incapacitatesContinue Reading

THURSDAY, Jan. 5, 2023 (HealthDay News) — Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administration, with a decision expected by Jan. 6. However, the drug hasContinue Reading

TUESDAY, Jan. 3, 2023 (HealthDay News) — It’s safe for kids to take the COVID-19 vaccine after they’ve suffered a rare complication from a prior COVID infection, a U.S. National Institutes of Health-supported study has concluded. Multisystem inflammatory syndrome in children (MIS-C) affects about 1 in every 3,000 to 4,000Continue Reading

TUESDAY, Dec. 27, 2022 (HealthDay News) — Living in an area with easy access to parks and rivers appears to slow the progression of devastating neurological diseases, such as Alzheimer’s and Parkinson’s. That’s the conclusion of a new study based on more than a decade and a half tracking diseaseContinue Reading

THURSDAY, Dec. 22, 2022 (HealthDay News) — Researchers are studying whether deep brain stimulation could help people with Alzheimer’s hold on to their memory longer, and now a new finding may help refine the approach. Deep brain stimulation (DBS) is an established treatment for several medical conditions, including epilepsy, Parkinson’sContinue Reading

WEDNESDAY, Dec. 21, 2022 (HealthDay News) — Groups of whales, dolphins and porpoises are regularly stranded in shallow waters around the coasts of the United Kingdom. Researchers wanted to understand why, so they studied the brains of 22 toothed whales — or “odontocetes” — that were stranded in Scottish coastalContinue Reading

THURSDAY, Dec. 15, 2022 (HealthDay News) — Parkinson’s disease is a much bigger problem than previously thought, particularly for aging Americans, a new study finds. There are about 50% more new cases of the degenerative disorder diagnosed each year in North America than currently estimated, researchers concluded after an extensiveContinue Reading